Global Leuprolide Market Growth (Status and Outlook) 2022-2028

Publisher Name :
Date: 11-Feb-2022
No. of pages: 124

As the global economy mends, the 2021 growth of Leuprolide will have significant change from previous year. According to our (LP Information) latest study, the global Leuprolide market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Leuprolide market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Leuprolide market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Leuprolide market, reaching US$ million by the year 2028. As for the Europe Leuprolide landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Leuprolide players cover TOLMAR PHARMACEUTICALS, Sanofi, Teva, and Sandoz (Novartis), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Leuprolide market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

- Subcutaneous

- Topical

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

- Breast Cancer

- Endometriosis

- Precocious Puberty

- Prostate Cancer

- Uterine Fibrosis

- Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

- TOLMAR PHARMACEUTICALS

- Sanofi

- Teva

- Sandoz (Novartis)

- Sun Pharmaceutical

- AbbVie

- Bayer

- Takeda

- Beijing Boente Pharmaceutical

- Livzon Pharmaceutical

- Selleck

- Hangzhou Peptide Biochemical

- Chengdu Shenguo Biological Pharmaceutical

- SciAnda Pharma

- Daewoong

- GP Pharm

- Enteris BioPharma

- Chong Kun Dang

- Leadiant Biosciences

- Hikma Pharmaceuticals

- Lee Pharma

- Hanall

Global Leuprolide Market Growth (Status and Outlook) 2022-2028

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Leuprolide Market Size 2017-2028
2.1.2 Leuprolide Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Leuprolide Segment by Type
2.2.1 Subcutaneous
2.2.2 Topical
2.3 Leuprolide Market Size by Type
2.3.1 Leuprolide Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Leuprolide Market Size Market Share by Type (2017-2022)
2.4 Leuprolide Segment by Application
2.4.1 Breast Cancer
2.4.2 Endometriosis
2.4.3 Precocious Puberty
2.4.4 Prostate Cancer
2.4.5 Uterine Fibrosis
2.4.6 Other
2.5 Leuprolide Market Size by Application
2.5.1 Leuprolide Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Leuprolide Market Size Market Share by Application (2017-2022)
3 Leuprolide Market Size by Player
3.1 Leuprolide Market Size Market Share by Players
3.1.1 Global Leuprolide Revenue by Players (2020-2022)
3.1.2 Global Leuprolide Revenue Market Share by Players (2020-2022)
3.2 Global Leuprolide Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Leuprolide by Regions
4.1 Leuprolide Market Size by Regions (2017-2022)
4.2 Americas Leuprolide Market Size Growth (2017-2022)
4.3 APAC Leuprolide Market Size Growth (2017-2022)
4.4 Europe Leuprolide Market Size Growth (2017-2022)
4.5 Middle East & Africa Leuprolide Market Size Growth (2017-2022)
5 Americas
5.1 Americas Leuprolide Market Size by Country (2017-2022)
5.2 Americas Leuprolide Market Size by Type (2017-2022)
5.3 Americas Leuprolide Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Leuprolide Market Size by Region (2017-2022)
6.2 APAC Leuprolide Market Size by Type (2017-2022)
6.3 APAC Leuprolide Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Leuprolide by Country (2017-2022)
7.2 Europe Leuprolide Market Size by Type (2017-2022)
7.3 Europe Leuprolide Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Leuprolide by Region (2017-2022)
8.2 Middle East & Africa Leuprolide Market Size by Type (2017-2022)
8.3 Middle East & Africa Leuprolide Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Leuprolide Market Forecast
10.1 Global Leuprolide Forecast by Regions (2023-2028)
10.1.1 Global Leuprolide Forecast by Regions (2023-2028)
10.1.2 Americas Leuprolide Forecast
10.1.3 APAC Leuprolide Forecast
10.1.4 Europe Leuprolide Forecast
10.1.5 Middle East & Africa Leuprolide Forecast
10.2 Americas Leuprolide Forecast by Country (2023-2028)
10.2.1 United States Leuprolide Market Forecast
10.2.2 Canada Leuprolide Market Forecast
10.2.3 Mexico Leuprolide Market Forecast
10.2.4 Brazil Leuprolide Market Forecast
10.3 APAC Leuprolide Forecast by Region (2023-2028)
10.3.1 China Leuprolide Market Forecast
10.3.2 Japan Leuprolide Market Forecast
10.3.3 Korea Leuprolide Market Forecast
10.3.4 Southeast Asia Leuprolide Market Forecast
10.3.5 India Leuprolide Market Forecast
10.3.6 Australia Leuprolide Market Forecast
10.4 Europe Leuprolide Forecast by Country (2023-2028)
10.4.1 Germany Leuprolide Market Forecast
10.4.2 France Leuprolide Market Forecast
10.4.3 UK Leuprolide Market Forecast
10.4.4 Italy Leuprolide Market Forecast
10.4.5 Russia Leuprolide Market Forecast
10.5 Middle East & Africa Leuprolide Forecast by Region (2023-2028)
10.5.1 Egypt Leuprolide Market Forecast
10.5.2 South Africa Leuprolide Market Forecast
10.5.3 Israel Leuprolide Market Forecast
10.5.4 Turkey Leuprolide Market Forecast
10.5.5 GCC Countries Leuprolide Market Forecast
10.6 Global Leuprolide Forecast by Type (2023-2028)
10.7 Global Leuprolide Forecast by Application (2023-2028)

11 Key Players Analysis
11.1 TOLMAR PHARMACEUTICALS
11.1.1 TOLMAR PHARMACEUTICALS Company Information
11.1.2 TOLMAR PHARMACEUTICALS Leuprolide Product Offered
11.1.3 TOLMAR PHARMACEUTICALS Leuprolide Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 TOLMAR PHARMACEUTICALS Main Business Overview
11.1.5 TOLMAR PHARMACEUTICALS Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Leuprolide Product Offered
11.2.3 Sanofi Leuprolide Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 Teva
11.3.1 Teva Company Information
11.3.2 Teva Leuprolide Product Offered
11.3.3 Teva Leuprolide Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Teva Main Business Overview
11.3.5 Teva Latest Developments
11.4 Sandoz (Novartis)
11.4.1 Sandoz (Novartis) Company Information
11.4.2 Sandoz (Novartis) Leuprolide Product Offered
11.4.3 Sandoz (Novartis) Leuprolide Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Sandoz (Novartis) Main Business Overview
11.4.5 Sandoz (Novartis) Latest Developments
11.5 Sun Pharmaceutical
11.5.1 Sun Pharmaceutical Company Information
11.5.2 Sun Pharmaceutical Leuprolide Product Offered
11.5.3 Sun Pharmaceutical Leuprolide Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Sun Pharmaceutical Main Business Overview
11.5.5 Sun Pharmaceutical Latest Developments
11.6 AbbVie
11.6.1 AbbVie Company Information
11.6.2 AbbVie Leuprolide Product Offered
11.6.3 AbbVie Leuprolide Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 AbbVie Main Business Overview
11.6.5 AbbVie Latest Developments
11.7 Bayer
11.7.1 Bayer Company Information
11.7.2 Bayer Leuprolide Product Offered
11.7.3 Bayer Leuprolide Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Bayer Main Business Overview
11.7.5 Bayer Latest Developments
11.8 Takeda
11.8.1 Takeda Company Information
11.8.2 Takeda Leuprolide Product Offered
11.8.3 Takeda Leuprolide Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Takeda Main Business Overview
11.8.5 Takeda Latest Developments
11.9 Beijing Boente Pharmaceutical
11.9.1 Beijing Boente Pharmaceutical Company Information
11.9.2 Beijing Boente Pharmaceutical Leuprolide Product Offered
11.9.3 Beijing Boente Pharmaceutical Leuprolide Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Beijing Boente Pharmaceutical Main Business Overview
11.9.5 Beijing Boente Pharmaceutical Latest Developments
11.10 Livzon Pharmaceutical
11.10.1 Livzon Pharmaceutical Company Information
11.10.2 Livzon Pharmaceutical Leuprolide Product Offered
11.10.3 Livzon Pharmaceutical Leuprolide Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Livzon Pharmaceutical Main Business Overview
11.10.5 Livzon Pharmaceutical Latest Developments
11.11 Selleck
11.11.1 Selleck Company Information
11.11.2 Selleck Leuprolide Product Offered
11.11.3 Selleck Leuprolide Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Selleck Main Business Overview
11.11.5 Selleck Latest Developments
11.12 Hangzhou Peptide Biochemical
11.12.1 Hangzhou Peptide Biochemical Company Information
11.12.2 Hangzhou Peptide Biochemical Leuprolide Product Offered
11.12.3 Hangzhou Peptide Biochemical Leuprolide Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Hangzhou Peptide Biochemical Main Business Overview
11.12.5 Hangzhou Peptide Biochemical Latest Developments
11.13 Chengdu Shenguo Biological Pharmaceutical
11.13.1 Chengdu Shenguo Biological Pharmaceutical Company Information
11.13.2 Chengdu Shenguo Biological Pharmaceutical Leuprolide Product Offered
11.13.3 Chengdu Shenguo Biological Pharmaceutical Leuprolide Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Chengdu Shenguo Biological Pharmaceutical Main Business Overview
11.13.5 Chengdu Shenguo Biological Pharmaceutical Latest Developments
11.14 SciAnda Pharma
11.14.1 SciAnda Pharma Company Information
11.14.2 SciAnda Pharma Leuprolide Product Offered
11.14.3 SciAnda Pharma Leuprolide Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 SciAnda Pharma Main Business Overview
11.14.5 SciAnda Pharma Latest Developments
11.15 Daewoong
11.15.1 Daewoong Company Information
11.15.2 Daewoong Leuprolide Product Offered
11.15.3 Daewoong Leuprolide Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Daewoong Main Business Overview
11.15.5 Daewoong Latest Developments
11.16 GP Pharm
11.16.1 GP Pharm Company Information
11.16.2 GP Pharm Leuprolide Product Offered
11.16.3 GP Pharm Leuprolide Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 GP Pharm Main Business Overview
11.16.5 GP Pharm Latest Developments
11.17 Enteris BioPharma
11.17.1 Enteris BioPharma Company Information
11.17.2 Enteris BioPharma Leuprolide Product Offered
11.17.3 Enteris BioPharma Leuprolide Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Enteris BioPharma Main Business Overview
11.17.5 Enteris BioPharma Latest Developments
11.18 Chong Kun Dang
11.18.1 Chong Kun Dang Company Information
11.18.2 Chong Kun Dang Leuprolide Product Offered
11.18.3 Chong Kun Dang Leuprolide Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Chong Kun Dang Main Business Overview
11.18.5 Chong Kun Dang Latest Developments
11.19 Leadiant Biosciences
11.19.1 Leadiant Biosciences Company Information
11.19.2 Leadiant Biosciences Leuprolide Product Offered
11.19.3 Leadiant Biosciences Leuprolide Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Leadiant Biosciences Main Business Overview
11.19.5 Leadiant Biosciences Latest Developments
11.20 Hikma Pharmaceuticals
11.20.1 Hikma Pharmaceuticals Company Information
11.20.2 Hikma Pharmaceuticals Leuprolide Product Offered
11.20.3 Hikma Pharmaceuticals Leuprolide Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Hikma Pharmaceuticals Main Business Overview
11.20.5 Hikma Pharmaceuticals Latest Developments
11.21 Lee Pharma
11.21.1 Lee Pharma Company Information
11.21.2 Lee Pharma Leuprolide Product Offered
11.21.3 Lee Pharma Leuprolide Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Lee Pharma Main Business Overview
11.21.5 Lee Pharma Latest Developments
11.22 Hanall
11.22.1 Hanall Company Information
11.22.2 Hanall Leuprolide Product Offered
11.22.3 Hanall Leuprolide Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 Hanall Main Business Overview
11.22.5 Hanall Latest Developments
12 Research Findings and Conclusion

List of Tables
Table 1. Leuprolide Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Subcutaneous
Table 3. Major Players of Topical
Table 4. Leuprolide Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Leuprolide Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Leuprolide Market Size Market Share by Type (2017-2022)
Table 7. Leuprolide Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Leuprolide Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Leuprolide Market Size Market Share by Application (2017-2022)
Table 10. Global Leuprolide Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Leuprolide Revenue Market Share by Player (2020-2022)
Table 12. Leuprolide Key Players Head office and Products Offered
Table 13. Leuprolide Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Leuprolide Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Leuprolide Market Size Market Share by Regions (2017-2022)
Table 18. Americas Leuprolide Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Leuprolide Market Size Market Share by Country (2017-2022)
Table 20. Americas Leuprolide Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Leuprolide Market Size Market Share by Type (2017-2022)
Table 22. Americas Leuprolide Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Leuprolide Market Size Market Share by Application (2017-2022)
Table 24. APAC Leuprolide Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Leuprolide Market Size Market Share by Region (2017-2022)
Table 26. APAC Leuprolide Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Leuprolide Market Size Market Share by Type (2017-2022)
Table 28. APAC Leuprolide Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Leuprolide Market Size Market Share by Application (2017-2022)
Table 30. Europe Leuprolide Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Leuprolide Market Size Market Share by Country (2017-2022)
Table 32. Europe Leuprolide Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Leuprolide Market Size Market Share by Type (2017-2022)
Table 34. Europe Leuprolide Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Leuprolide Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Leuprolide Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Leuprolide Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Leuprolide Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Leuprolide Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Leuprolide Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Leuprolide Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Leuprolide
Table 43. Key Market Challenges & Risks of Leuprolide
Table 44. Key Industry Trends of Leuprolide
Table 45. Global Leuprolide Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Leuprolide Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Leuprolide Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Leuprolide Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Leuprolide Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Leuprolide Market Size Market Share Forecast by Application (2023-2028)
Table 51. TOLMAR PHARMACEUTICALS Details, Company Type, Leuprolide Area Served and Its Competitors
Table 52. TOLMAR PHARMACEUTICALS Leuprolide Product Offered
Table 53. TOLMAR PHARMACEUTICALS Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. TOLMAR PHARMACEUTICALS Main Business
Table 55. TOLMAR PHARMACEUTICALS Latest Developments
Table 56. Sanofi Details, Company Type, Leuprolide Area Served and Its Competitors
Table 57. Sanofi Leuprolide Product Offered
Table 58. Sanofi Main Business
Table 59. Sanofi Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Sanofi Latest Developments
Table 61. Teva Details, Company Type, Leuprolide Area Served and Its Competitors
Table 62. Teva Leuprolide Product Offered
Table 63. Teva Main Business
Table 64. Teva Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Teva Latest Developments
Table 66. Sandoz (Novartis) Details, Company Type, Leuprolide Area Served and Its Competitors
Table 67. Sandoz (Novartis) Leuprolide Product Offered
Table 68. Sandoz (Novartis) Main Business
Table 69. Sandoz (Novartis) Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Sandoz (Novartis) Latest Developments
Table 71. Sun Pharmaceutical Details, Company Type, Leuprolide Area Served and Its Competitors
Table 72. Sun Pharmaceutical Leuprolide Product Offered
Table 73. Sun Pharmaceutical Main Business
Table 74. Sun Pharmaceutical Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Sun Pharmaceutical Latest Developments
Table 76. AbbVie Details, Company Type, Leuprolide Area Served and Its Competitors
Table 77. AbbVie Leuprolide Product Offered
Table 78. AbbVie Main Business
Table 79. AbbVie Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. AbbVie Latest Developments
Table 81. Bayer Details, Company Type, Leuprolide Area Served and Its Competitors
Table 82. Bayer Leuprolide Product Offered
Table 83. Bayer Main Business
Table 84. Bayer Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Bayer Latest Developments
Table 86. Takeda Details, Company Type, Leuprolide Area Served and Its Competitors
Table 87. Takeda Leuprolide Product Offered
Table 88. Takeda Main Business
Table 89. Takeda Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Takeda Latest Developments
Table 91. Beijing Boente Pharmaceutical Details, Company Type, Leuprolide Area Served and Its Competitors
Table 92. Beijing Boente Pharmaceutical Leuprolide Product Offered
Table 93. Beijing Boente Pharmaceutical Main Business
Table 94. Beijing Boente Pharmaceutical Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Beijing Boente Pharmaceutical Latest Developments
Table 96. Livzon Pharmaceutical Details, Company Type, Leuprolide Area Served and Its Competitors
Table 97. Livzon Pharmaceutical Leuprolide Product Offered
Table 98. Livzon Pharmaceutical Main Business
Table 99. Livzon Pharmaceutical Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Livzon Pharmaceutical Latest Developments
Table 101. Selleck Details, Company Type, Leuprolide Area Served and Its Competitors
Table 102. Selleck Leuprolide Product Offered
Table 103. Selleck Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Selleck Main Business
Table 105. Selleck Latest Developments
Table 106. Hangzhou Peptide Biochemical Details, Company Type, Leuprolide Area Served and Its Competitors
Table 107. Hangzhou Peptide Biochemical Leuprolide Product Offered
Table 108. Hangzhou Peptide Biochemical Main Business
Table 109. Hangzhou Peptide Biochemical Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. Hangzhou Peptide Biochemical Latest Developments
Table 111. Chengdu Shenguo Biological Pharmaceutical Details, Company Type, Leuprolide Area Served and Its Competitors
Table 112. Chengdu Shenguo Biological Pharmaceutical Leuprolide Product Offered
Table 113. Chengdu Shenguo Biological Pharmaceutical Main Business
Table 114. Chengdu Shenguo Biological Pharmaceutical Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Chengdu Shenguo Biological Pharmaceutical Latest Developments
Table 116. SciAnda Pharma Details, Company Type, Leuprolide Area Served and Its Competitors
Table 117. SciAnda Pharma Leuprolide Product Offered
Table 118. SciAnda Pharma Main Business
Table 119. SciAnda Pharma Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. SciAnda Pharma Latest Developments
Table 121. Daewoong Details, Company Type, Leuprolide Area Served and Its Competitors
Table 122. Daewoong Leuprolide Product Offered
Table 123. Daewoong Main Business
Table 124. Daewoong Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 125. Daewoong Latest Developments
Table 126. GP Pharm Details, Company Type, Leuprolide Area Served and Its Competitors
Table 127. GP Pharm Leuprolide Product Offered
Table 128. GP Pharm Main Business
Table 129. GP Pharm Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 130. GP Pharm Latest Developments
Table 131. Enteris BioPharma Details, Company Type, Leuprolide Area Served and Its Competitors
Table 132. Enteris BioPharma Leuprolide Product Offered
Table 133. Enteris BioPharma Main Business
Table 134. Enteris BioPharma Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 135. Enteris BioPharma Latest Developments
Table 136. Chong Kun Dang Details, Company Type, Leuprolide Area Served and Its Competitors
Table 137. Chong Kun Dang Leuprolide Product Offered
Table 138. Chong Kun Dang Main Business
Table 139. Chong Kun Dang Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 140. Chong Kun Dang Latest Developments
Table 141. Leadiant Biosciences Details, Company Type, Leuprolide Area Served and Its Competitors
Table 142. Leadiant Biosciences Leuprolide Product Offered
Table 143. Leadiant Biosciences Main Business
Table 144. Leadiant Biosciences Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 145. Leadiant Biosciences Latest Developments
Table 146. Hikma Pharmaceuticals Details, Company Type, Leuprolide Area Served and Its Competitors
Table 147. Hikma Pharmaceuticals Leuprolide Product Offered
Table 148. Hikma Pharmaceuticals Main Business
Table 149. Hikma Pharmaceuticals Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 150. Hikma Pharmaceuticals Latest Developments
Table 151. Lee Pharma Details, Company Type, Leuprolide Area Served and Its Competitors
Table 152. Lee Pharma Leuprolide Product Offered
Table 153. Lee Pharma Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 154. Lee Pharma Main Business
Table 155. Lee Pharma Latest Developments
Table 156. Hanall Details, Company Type, Leuprolide Area Served and Its Competitors
Table 157. Hanall Leuprolide Product Offered
Table 158. Hanall Main Business
Table 159. Hanall Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 160. Hanall Latest Developments
List of Figures
Figure 1. Leuprolide Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Leuprolide Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Leuprolide Market Size Market Share by Type in 2021
Figure 7. Leuprolide in Breast Cancer
Figure 8. Global Leuprolide Market: Breast Cancer (2017-2022) & ($ Millions)
Figure 9. Leuprolide in Endometriosis
Figure 10. Global Leuprolide Market: Endometriosis (2017-2022) & ($ Millions)
Figure 11. Leuprolide in Precocious Puberty
Figure 12. Global Leuprolide Market: Precocious Puberty (2017-2022) & ($ Millions)
Figure 13. Leuprolide in Prostate Cancer
Figure 14. Global Leuprolide Market: Prostate Cancer (2017-2022) & ($ Millions)
Figure 15. Leuprolide in Uterine Fibrosis
Figure 16. Global Leuprolide Market: Uterine Fibrosis (2017-2022) & ($ Millions)
Figure 17. Leuprolide in Other
Figure 18. Global Leuprolide Market: Other (2017-2022) & ($ Millions)
Figure 19. Global Leuprolide Market Size Market Share by Application in 2021
Figure 20. Global Leuprolide Revenue Market Share by Player in 2021
Figure 21. Global Leuprolide Market Size Market Share by Regions (2017-2022)
Figure 22. Americas Leuprolide Market Size 2017-2022 ($ Millions)
Figure 23. APAC Leuprolide Market Size 2017-2022 ($ Millions)
Figure 24. Europe Leuprolide Market Size 2017-2022 ($ Millions)
Figure 25. Middle East & Africa Leuprolide Market Size 2017-2022 ($ Millions)
Figure 26. Americas Leuprolide Value Market Share by Country in 2021
Figure 27. Americas Leuprolide Consumption Market Share by Type in 2021
Figure 28. Americas Leuprolide Market Size Market Share by Application in 2021
Figure 29. United States Leuprolide Market Size Growth 2017-2022 ($ Millions)
Figure 30. Canada Leuprolide Market Size Growth 2017-2022 ($ Millions)
Figure 31. Mexico Leuprolide Market Size Growth 2017-2022 ($ Millions)
Figure 32. Brazil Leuprolide Market Size Growth 2017-2022 ($ Millions)
Figure 33. APAC Leuprolide Market Size Market Share by Region in 2021
Figure 34. APAC Leuprolide Market Size Market Share by Application in 2021
Figure 35. China Leuprolide Market Size Growth 2017-2022 ($ Millions)
Figure 36. Japan Leuprolide Market Size Growth 2017-2022 ($ Millions)
Figure 37. Korea Leuprolide Market Size Growth 2017-2022 ($ Millions)
Figure 38. Southeast Asia Leuprolide Market Size Growth 2017-2022 ($ Millions)
Figure 39. India Leuprolide Market Size Growth 2017-2022 ($ Millions)
Figure 40. Australia Leuprolide Market Size Growth 2017-2022 ($ Millions)
Figure 41. Europe Leuprolide Market Size Market Share by Country in 2021
Figure 42. Europe Leuprolide Market Size Market Share by Type in 2021
Figure 43. Europe Leuprolide Market Size Market Share by Application in 2021
Figure 44. Germany Leuprolide Market Size Growth 2017-2022 ($ Millions)
Figure 45. France Leuprolide Market Size Growth 2017-2022 ($ Millions)
Figure 46. UK Leuprolide Market Size Growth 2017-2022 ($ Millions)
Figure 47. Italy Leuprolide Market Size Growth 2017-2022 ($ Millions)
Figure 48. Russia Leuprolide Market Size Growth 2017-2022 ($ Millions)
Figure 49. Middle East & Africa Leuprolide Market Size Market Share by Region in 2021
Figure 50. Middle East & Africa Leuprolide Market Size Market Share by Type in 2021
Figure 51. Middle East & Africa Leuprolide Market Size Market Share by Application in 2021
Figure 52. Egypt Leuprolide Market Size Growth 2017-2022 ($ Millions)
Figure 53. South Africa Leuprolide Market Size Growth 2017-2022 ($ Millions)
Figure 54. Israel Leuprolide Market Size Growth 2017-2022 ($ Millions)
Figure 55. Turkey Leuprolide Market Size Growth 2017-2022 ($ Millions)
Figure 56. GCC Country Leuprolide Market Size Growth 2017-2022 ($ Millions)
Figure 57. Americas Leuprolide Market Size 2023-2028 ($ Millions)
Figure 58. APAC Leuprolide Market Size 2023-2028 ($ Millions)
Figure 59. Europe Leuprolide Market Size 2023-2028 ($ Millions)
Figure 60. Middle East & Africa Leuprolide Market Size 2023-2028 ($ Millions)
Figure 61. United States Leuprolide Market Size 2023-2028 ($ Millions)
Figure 62. Canada Leuprolide Market Size 2023-2028 ($ Millions)
Figure 63. Mexico Leuprolide Market Size 2023-2028 ($ Millions)
Figure 64. Brazil Leuprolide Market Size 2023-2028 ($ Millions)
Figure 65. China Leuprolide Market Size 2023-2028 ($ Millions)
Figure 66. Japan Leuprolide Market Size 2023-2028 ($ Millions)
Figure 67. Korea Leuprolide Market Size 2023-2028 ($ Millions)
Figure 68. Southeast Asia Leuprolide Market Size 2023-2028 ($ Millions)
Figure 69. India Leuprolide Market Size 2023-2028 ($ Millions)
Figure 70. Australia Leuprolide Market Size 2023-2028 ($ Millions)
Figure 71. Germany Leuprolide Market Size 2023-2028 ($ Millions)
Figure 72. France Leuprolide Market Size 2023-2028 ($ Millions)
Figure 73. UK Leuprolide Market Size 2023-2028 ($ Millions)
Figure 74. Italy Leuprolide Market Size 2023-2028 ($ Millions)
Figure 75. Russia Leuprolide Market Size 2023-2028 ($ Millions)
Figure 76. Spain Leuprolide Market Size 2023-2028 ($ Millions)
Figure 77. Egypt Leuprolide Market Size 2023-2028 ($ Millions)
Figure 78. South Africa Leuprolide Market Size 2023-2028 ($ Millions)
Figure 79. Israel Leuprolide Market Size 2023-2028 ($ Millions)
Figure 80. Turkey Leuprolide Market Size 2023-2028 ($ Millions)
Figure 81. GCC Countries Leuprolide Market Size 2023-2028 ($ Millions)
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs